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Accumulating evidence suggests revascularization of peripheral arterial disease (PAD) limbs results in limited improvement in
functional gait parameters, suggesting underlying locomotor system pathology. Spatial and temporal (ST) gait parameters are
well studied in patients with PAD at baseline and are abnormal when compared to controls. The purpose of this study was
to systematically review and critically analyze the available data on ST gait parameters before and after interventions. A full
review of literature was conducted and articles were included which examined ST gait parameters before and after intervention
(revascularization and exercise). Thirty-three intervention articles were identified based on 154 articles that evaluated ST gait
parameters in PAD. Four articles fully assessed ST gait parameters before and after intervention and were included in our analysis.
The systematic review of the literature revealed a limited number of studies assessing ST gait parameters. Of those found, results
demonstrated the absence of improvement in gait parameters due to either exercise or surgical intervention. Our study demonstrates
significant lack of research examining the effectiveness of treatments on ST gait parameters in patients with PAD. Based on the four
published articles, ST gait parameters failed to significantly improve in patients with PAD following intervention.

1. Introduction
Peripheral arterial disease (PAD) is the result of atherosclerosis in the lower extremities, affecting 8 to 12 million people
in the United States and up to 30% of older adults [1, 2]. PAD
is often accompanied by intermittent claudication that occurs
due to ischemic conditions after lower extremity blood flow
decreases. Intermittent claudication is defined as pain occurring during physical exertion that ceases after rest. Patients
with PAD commonly present with intermittent claudication
after walking a short distance and complain of having to cease
physical activity to allow for reperfusion [3]. Thus, PAD is
a painful ambulatory disorder of the lower extremities that

originates during and ultimately halts ambulation. Underlying this ambulatory dysfunction are severe musculoskeletal
changes and myopathy [4–6] that may be related to abnormal
gait patterns and lead to a loss of function. Thus, PAD results
in reduced physical functioning and higher prevalence of
falling and is associated with increased cardiovascular morbidity and mortality [7, 8].
Ambulation requires the integration of numerous systems
and will reflect the overall burden of disease [9]. Spatial and
temporal (ST) gait parameters are commonly used to identify
abnormalities in ambulation and to monitor patient progress.
ST gait parameters have also been proposed as global markers
for health-related risk in older adults [10]. Walking velocity

2
alone has been shown to be an independent predictor of hospitalization and disability [11–13]. Variabilities in step length
and stance time have also been associated with increased
health problems, functional loss, and decreased physical
activity [14]. Consequently, evaluation of ST gait parameters
may be used as a surrogate measure to assess overall functional status.
Previous studies of patients with PAD have utilized measurement of ST gait parameters to document the functional
loss due to abnormal gait patterns that result from PAD [15–
18]. In particular, patients with PAD demonstrate decreased
walking velocity, cadence, step length, stride length, time
spent in single support, and increased time spent in double
support during pain-free conditions, when compared to control subjects [15, 19]. When patients are asked to walk while
experiencing claudication pain, further decrements in ST gait
parameters have been recorded [20]. With increasing deficits
in gait parameters as the disease progresses, there is a need
to investigate the efficacy of treatment programs for these
patients.
Several treatments are available to address functional loss
in PAD. Currently, primary medical treatments for patients
with PAD include revascularization, pharmacology, risk factor management (i.e., smoking cessation), and exercise programs that focus on restoring impaired physical functioning.
Several meta-analyses have been performed to evaluate the
effectiveness of different treatments on improving initial
claudication distance (also referred to as pain-free walking
distance) and the distance covered during the 6-minute walk
test [21–24]. It has been found that pharmacological treatments, pentoxifylline and cilostazol, significantly improve
initial claudication distance for patients with PAD up to six
months after the initiation of treatment [21, 22]. Supervised
treadmill training [23], strength training [25], and high intensity resistance training [26] have been shown to significantly
improve 6-minute walking distance while strength training
also improved initial claudication distance [27]. These walking distance-based measures provide only a general measure
of functional loss [28] and do not provide insight into
ambulatory dysfunction associated with PAD. Evaluation of
basic ST parameters of gait is a necessary first step to provide
such insight. Evaluation of the literature, however, reveals that
there has been no systematic review of studies utilizing ST
gait parameters to evaluate the effectiveness of treatments on
functional improvements.
The purpose of this study was to systematically review and
critically analyze available data on ST gait parameters, before
and after treatments, and consequently provide an overall
evaluation of changes in functional status posttreatment. If
sufficient studies have been conducted to evaluate ST gait
parameters before and after treatment, this review will shed
light on which treatments most effectively lead to functional
improvements. If insufficient studies have investigated ST
gait parameters before and after treatment, the review will
demonstrate the need for future studies of changes in ST gait
parameters following treatment of patients with peripheral
arterial disease.
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2. Methods
This review was performed following procedures outlined
in previous reviews of treatment outcomes for intermittent
claudication patients [29–31].
2.1. Literature Search Strategy. The search strategy was developed to identify all articles pertaining to basic ST gait parameters in patients with PAD. Databases searched were
PubMed (from 1950), EBSCO (from 1982), CINAHL (from
1982), Cochrane library (from 1900), and UMI Dissertation
(from 1963). Targeted searching of frequently cited journals,
authors, and article reference lists ensured that all relevant
articles were obtained.
For an article to be labeled relevant for review, it had
to contain words pertaining to basic ST gait parameters in
patients with PAD in the title, abstract, or keywords. Search
strings included “walking velocity and peripheral arterial
disease,” “cadence and peripheral arterial disease,” “stride
length and peripheral arterial disease,” “step width and peripheral arterial disease,” “walking velocity and intermittent
claudication,” “cadence and intermittent claudication,” “stride
length and intermittent claudication,” and “step width and
intermittent claudication.”
2.2. Study Selection. The initial search yield was obtained
by combining all original articles from online databases. All
original articles were available to the authors. Articles not
initially available were obtained via interlibrary loan. Articles
not pertaining to basic ST gait parameters in patients with
PAD were excluded during initial screening of titles and
abstracts by the reviewer (author: Neil B. Huben). The full text
of the remaining articles was then screened by the reviewer
(author: Neil B. Huben). There was no date restriction on
articles. Articles were required to be full text in English. The
articles containing mean and standard deviation information
for the basic ST gait parameters in patients with PAD were
further screened for the inclusion of pre- and posttreatment
data for walking velocity, cadence, stride length, and step
width parameters following treatment by two reviewers
(authors: Neil B. Huben and Jennifer M. Yentes).
2.3. Quality Assessment. For systematic literature reviews, it
is important to conduct a quality assessment to decrease
reviewer bias and increase standard of review [32]. In order
to conduct a systematic assessment, three reviewers (authors:
Jason M. Johanning, Neil B. Huben, and Jennifer M. Yentes)
developed a table checklist based on standardized techniques
presented in published reviews and literature sources on
systematic review principles [32–35].
The quality assessment table developed for the current
systematic review, Table 1, was formulated based on the fundamental research aims. Two reviewers (authors: Neil B. Huben
and Jennifer M. Yentes) analyzed and scored the quality of
each article independently. Differences in scores after independent analysis were discussed by the initial reviewers
(authors: Neil B. Huben and Jennifer M. Yentes), plus one
additional third-party reviewer (author: Sara A. Myers).
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Table 1: Summary of quality assessment for individual articles. The four articles shown are those selected for detailed review. Scoring criteria
employed: Yes, 1; inadequate, 0.5; no, 0.
Question

Crowther et
al. [36]

Gardner and
Killewich
[37]

Wullink et al.
[38]

McDermott et al. [39]

1
1

1
1

1
1

1
1

1
1
1
1
1
1
1
0.75
1
1

1
1
1
0
0
1
1
0.5
0
1

1
1
1
0
1
1
0.5
1
1
1

1
1
1
0
1
1
1
1
0
1

1
1
1
1
1
1
1
1
1
1

1
1
1
1
1
1
1
1
1
1

1
1
1
1
1
1
1
1
1
1

1
1
1
1
1
1
1
1
1
1

21.75

18.50

20.50

20.00

(1) Research aims stated
(2) Intervention clearly stated
(3) Patient demographics reported
Number
Age
Sex
Height
BMI
ABI
(4) Methods: recruitment explained
(5) Methods: inclusion and exclusion criteria reported
(6) Methods: control group
(7) Methods: adequate methodology reported
(8) Methods: methodology able to answer research question
Sample size
Equipment
Intervention
Data processing
Statistical analysis
(9) Methods: reliability of methodology
(10) Results: logical interpretation of data
(11) Results: reported key findings supported by data
(12) Discussion: research question answered adequately
(13) Discussion: clinical implications stated
Total

2.4. Data Extraction. A customized data extraction document which formed the questions for Table 1 was created and
agreed upon by two authors (authors: Jason M. Johanning
and Neil B. Huben) to ensure extraction reliability. The major
data extraction categories included type of treatment, anklebrachial index, walking velocity, cadence, stride length, and
step width. Data extraction was performed initially by one
reviewer (author: Neil B. Huben) and then checked by two
additional reviewers (authors: Jason M. Johanning and Jennifer M. Yentes).
2.5. Reliability of the Reviewing Process. The quality of the
selected articles was analyzed independently by two researchers (authors: Neil B. Huben and Jennifer M. Yentes). To
verify the reliability of quality assessment, two reviewers
(authors: Neil B. Huben and Jennifer M. Yentes) independently assessed a single, randomized pilot article and their
results were checked by a third reviewer (author: Sara A.
Myers). To verify the reliability of data extraction, data from a
single, randomized pilot article was independently extracted
by one reviewer (author: Neil B. Huben) and checked by a
second reviewer (author: Jason M. Johanning).

3. Results
3.1. Yield. The online database search resulted in an initial
yield of 153 articles related to PAD and gait (Figure 1). Of those
153 articles, 33 articles reported one or more basic ST gait
parameters (velocity, stride length, and cadence; Table 2). Of
those 33, 25 articles reported mean and standard deviations
of walking velocity, stride length, and cadence in patients
with PAD. No articles reported mean step width before
and after intervention. Of those 25, 9 examined the effects
of treatment on the above ST parameters. After searching
the electronic databases and references lists, the final yield
included four articles pertaining to the effect of treatments
on basic ST gait parameters in patients with PAD. The four
articles contained three treatments exploring exercise [36, 38,
39] and one treatment exploring revascularization [37]. None
of the articles that reported ST gait parameters before and
after pharmacological treatment were considered appropriate
for detailed consideration.
3.2. Quality of Reviewed Articles. The quality of the four
reviewed articles is reported in Tables 2 and 3. The reviewed
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PubMed

EBSCO

CINAHL

Cochrane

Initial yield of PAD gait articles
153
Articles reporting basic gait ST parameters
(walking velocity, stride length, and cadence)
33
Articles reporting mean and standard
deviation of gait ST parameters
25
Articles reporting effects of treatment
on basic gait ST parameters
9

UMI Dissertation

Articles without ST gait parameters
120
Articles not reporting mean and standard
deviation of gait ST parameters
8
Articles not reporting effects of
treatment on gait ST parameters
16
Articles not considered
suitable for review
5

Articles retained for review
4

Figure 1: Diagram showing the steps of the article selection procedure which resulted in four articles being selected for detailed review.

articles adequately stated the aims, performed a treatment,
reported sufficient patient demographics, stated inclusion
and exclusion criteria, reported adequate methodology, logically interpreted results, and adequately answered the
research questions. Furthermore, the clinical implications
were stated in each article.
3.3. Demographics. Within the four articles, 66 patients with
PAD and 30 controls were enrolled and completed a baseline
measurement and at least one posttreatment measurement
with respect to the basic gait parameters of interest (e.g.,
walking velocity, cadence, and stride length). These results are
reported in Table 3. All four articles reported pre- and posttreatment walking velocity [36–39]. Two articles reported
pre- and posttreatment cadence [36, 37]. Two articles reported pre- and posttreatment stride length [36, 37]. Importantly,
no statistically significant differences were reported for the
effect of treatments on walking velocity, cadence, or stride
length in any of the articles.

4. Study Outcomes
All outcomes (ankle-brachial index, walking velocity, cadence, and stride length) of the studies are shown in Table 3.
These results are presented based on intervention type: revascularization and exercise. Due to the different interventions,
and because outcomes were assessed at a different treatment
length for each exercise study, the data could not be pooled.
Thus, the results of the individual studies are concisely stated
in Sections 4.1 and 4.2.
4.1. Revascularization. One study examined functional status
before and three-to-four months after infrainguinal bypass
in 20 symptomatic patients with Fontaine stage III or IV
PAD [37]. Results of the study indicated significant improvements in resting ankle-brachial index; however, no significant

changes were reported for walking velocity, cadence, or step
length.
4.2. Exercise. Three studies evaluated ST gait parameters
at baseline and following an exercise intervention in PAD
patients. Of those three studies, one included walking velocity, cadence, and stride length as outcome measures [36] and
two others included walking velocity only [38, 39]. Regarding
length of intervention, one study evaluated patients after 12
months [36], one study after six months [38], and one study
after three months [39], respectively. None of the three studies
found significant improvements in the outcome measures
following intervention.

5. Discussion
ST gait parameters provide an overall marker of functional
status and health risk in older adults [9, 10] and are associated
with disability and hospitalization in older adults [10]. Thus,
examining ST gait parameters will provide a vital understanding of the functional status of patients with PAD. From
the results of the current systematic literature review, it has
been demonstrated that there is lack of studies evaluating ST
gait parameters before and after treatment therapies. Specifically, we were unable to find any study that appropriately
reported ST gait parameters before and after pharmacological
treatment. Further, only one study was found that reported
ST gait parameters before and after revascularization. The
systematic review of literature in conjunction with the current
experimental findings found no significant ST gait parameter
changes (walking velocity, cadence, and stride length) due to
either exercise or revascularization. Taken as a whole, our
current study demonstrates the need for further research to
evaluate treatment therapies with a clear and specific focus
on ST and more detailed gait parameters. Though limited in

Altered Gait Profile in Subjects with Peripheral Arterial Disease
Natural History of Physical Function in Older Men with Intermittent Claudication
Lack of Functional Benefits following Infrainguinal Bypass in Peripheral
Arterial Occlusive Disease Patients

Chen et al. (2008)

Crowther et al. (2007)

Crowther et al. (2008)

Dolan et al. (2002)

Gardner et al. (2001)

Gardner et al. (2004)

Gardner and Killewich
(2001)

Giri et al. (2006)

Kuo and Yu (2008)

McCully et al. (1999)

[18]

[20]

[36]

[41]

[19]

[42]

[37]

[43]

[44]

[45]

[46]

McDermott et al. (2004)

McDermott et al. (2008)

McDermott et al. (2003)

McDermott et al. (2003)

[17]

[49]

[50]

None

Statin

None

None

None

[48]

Leg Symptoms in Peripheral Arterial Disease: Associated Clinical Characteristics
and Functional Impairment
Functional Decline in Peripheral Arterial Disease: Associations with the Ankle
Brachial Index and Leg Symptoms
Asymptomatic Peripheral Arterial Disease Is Associated with More Adverse Lower
Extremity Characteristics Than Intermittent Claudication
Statin Use and Leg Functioning in Patients with and without Lower-Extremity
Peripheral Arterial Disease
Depressive Symptoms and Lower Extremity Functioning in Men and Women with
Peripheral Arterial Disease

McDermott et al. (2001)

[47]

Velocity

Velocity

Velocity

Velocity

Velocity

N

Y

N

Y

Y

N

Velocity,
cadence, and
stride length
None

Gait Alterations Associated with Walking Impairment in People with Peripheral
Arterial Disease with and without Intermittent Claudication

McDermott et al. (2001)

[2]

Y

None

Asymptomatic Peripheral Arterial Disease Is Independently Associated with
Impaired Lower Extremity Functioning: The Women’s Health and Aging Study

McDermott et al. (2000)

Y

Y

Y

Y

Y

Y

N

Y

Y

Y

Y

Mean ± SD

Velocity

Velocity, stride
length

Treadmill
(immediate)

The Effects of Peripheral Vascular Disease on Gait

Velocity

Velocity,
cadence, and
stride length
Velocity,
cadence, and
stride length
Velocity,
cadence, and
stride length
Velocity
Velocity,
cadence, and
stride length
Velocity
Velocity,
cadence, and
stride length

Velocity

Gait parameters

Velocity

Statin

Bypass

Time

None

None

Exercise
program

None

None

None

Treatment

None

Statin Use and Functional Decline in Patients with and without Peripheral Arterial
Disease
The Relation of Peripheral Arterial Disease to Leg Force, Gait Speed, and Functional
Dependence among Older Adults

Relationship between Temporal-Spatial Gait Parameters, Gait Kinematics, Walking
Performance, Exercise Capacity, and Physical Activity Level in Peripheral Arterial
Disease
Effects of a Long-Term Exercise Program on Lower Limb Mobility, Physiological
Responses, Walking Performance, and Physical Activity Levels in Patients with
Peripheral Arterial Disease
Peripheral Artery Disease, Diabetes, and Reduced Lower Extremity Functioning

Bilateral Intermittent Claudication Results in Alterations in the Gait Biomechanics
at the Hip and Ankle Joints during Gait

Arseven et al. (2007)

[40]

Title
Does Lower-Extremity Arterial Disease Predict Future Falling among Older Men
and Women?

Reference

Ref. number

Table 2: List of articles resulting from a search of literature databases (PubMed, EBSCO, CINAHL, Cochrane library, and UMI Dissertation). Only the articles containing basic ST gait
parameters are listed. Articles shown in bold print contained information pertaining to the effect of treatment on basic ST gait parameters in patients with PAD, which met the criteria for
detailed review.
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None

None
Walking
exercise

Gait Characteristics of Patients with Claudication
Lack of Relationship between Gait Parameters and Physical Function in Peripheral
Arterial Disease
A Primary Care Walking Exercise Program for Patients with Intermittent
Claudication

McDermott et al. (2006)

McDermott et al. (1998)

McDermott et al. (2007)

McDermott et al. (2007)

McDermott et al. (2004)

McDermott et al.
(2006)

McDermott et al. (2004)

McDermott et al. (2003)

McDermott et al.
(2004)

McDermott et al. (2007)

Rucker-Whitaker et al.
(2004)

Scherer et al. (1998)

Scherer et al. (2006)

Wullink et al. (2001)

[52]

[53]

[54]

[55]

[56]

[57]

[58]

[59]

[39]

[60]

[61]

[15]

[62]

[38]

None

None

Exercise
program

None

None

Time

None

None

None

None

None

None

McDermott et al. (2005)

Treatment

[51]

Title
Functional Decline in Lower-Extremity Peripheral Arterial Disease: Associations
with Comorbidity, Gender, and Race
Obesity, Weight Change, and Functional Decline in Peripheral Arterial Disease
Measurement of Walking Endurance and Walking Velocity with Questionnaire:
Validation of the Walking Impairment Questionnaire in Men and Women with
Peripheral Arterial Disease
Baseline Functional Performance Predicts the Rate of Mobility Loss in Persons with
Peripheral Arterial Disease
Physical Activity, Walking Exercise, and Calf Skeletal Muscle Characteristics in
Patients with Peripheral Arterial Disease
Leg Strength in Peripheral Arterial Disease: Associations with Disease Severity and
Lower-Extremity Performance
Functional Decline in Patients with and without Peripheral Arterial Disease:
Predictive Value of Annual Changes in Levels of C-Reactive Protein and D-Dimer
Inflammatory and Thrombotic Blood Markers and Walking-Related Disability in
Men and Women with and without Peripheral Arterial Disease
Sex Differences in Peripheral Arterial Disease: Leg Symptoms and Physical
Functioning
A Pilot Exercise Intervention to Improve Lower Extremity Functioning in
Peripheral Arterial Disease Unaccompanied by Intermittent Claudication
Lower Extremity Ischemia, Calf Skeletal Muscle Characteristics, and Functional
Impairment in Peripheral Arterial Disease
Peripheral Arterial Disease in African Americans: Clinical Characteristics, Leg
Symptoms, and Lower Extremity Functioning

Reference

Ref. number

Table 2: Continued.

Velocity

Velocity,
cadence, and
stride length
Velocity,
cadence, and
stride length

Velocity

Velocity

Velocity

Velocity

Velocity

Velocity

Velocity

Velocity

Velocity

Velocity

Velocity

Velocity

Gait parameters

CI

Y

Y

N

Y

Y

N

Y

Y

N

Y

Y

Y

N

Y

Mean ± SD
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Table 3: Study information and parameters reported for the four articles that contained information pertaining to the effect of treatment on
basic ST gait parameters in patients with PAD, which were selected for detailed analysis.
Study
Number of subjects
Number of controls
Intervention
Time (months)
Parameters reported∗
Ankle-brachial index
Walking velocity
Cadence
Stride length

Crowther et al. [36]
10
11
Exercise
12

McDermott et al. [39]
24
—
Exercise
6

Wullink et al. [38]
17
8
Exercise
3

Gardner and Killewich [37]
20
—
Bypass
3-4

P
P
P
P

P
P
—
—

P#
P
—
—

P
P
P
P

∗
#

Mean and standard deviation of the listed parameters were reported.
Postintervention measurements were not reported.

nature, the available studies demonstrate that treatments do
not change ST gait abnormalities [36–39].
One potential reason behind the failure of revascularization to elicit change could be inability of revascularization to
reverse the known myopathic damage in patients with PAD.
Patients with symptomatic PAD suffer from lower extremity
cellular abnormalities. Such abnormalities include axonal
nerve loss and mitochondrial dysfunction [4–6], which could
explain the failure to elicit change with revascularization.
Lack of differences before and after revascularization could
also suggest that even more detailed methods of gait analysis
may be necessary to evaluate the effectiveness of currently
available treatments. It is possible that ST gait parameters
were not sensitive enough to detect the effect of these treatments. Studies of patients with PAD have demonstrated
decreased walking velocity, cadence, stride length, and singlesupport phase and increased double-support phase as compared to controls during pain-free conditions [15, 19]. When
patients are asked to walk during claudication pain, further
decrements in ST gait parameters are demonstrated [20].
However, two studies that have compared patients with PAD
with or without intermittent claudication to controls found
no significant differences in ST parameters [2, 45]. These
conflicting results have questioned the sensitivity of ST gait
parameters to detect differences in gait of patients with PAD.
In contrast, advanced biomechanical analysis has revealed
changes due to treatment, in previous studies of orthotics,
prosthetics, and the elderly, when no change in ST gait
parameters has been demonstrated [63, 64]. It may be necessary, therefore, to use advanced biomechanical analysis of
joint torques and powers, to confirm whether ST parameters
are sensitive enough to evaluate the effectiveness of various
treatments used for PAD [18, 65, 66].
Advanced biomechanical analyses allow an objective
measurement of the joint muscular responses and contributions to walking during every instance of the gait cycle.
Several studies in patients with PAD have included advanced
biomechanical gait analysis beyond ST gait parameters,
demonstrating abnormal joint kinematics and kinetics [18,
20, 65, 66]. Patients with PAD have significantly reduced
ankle plantar-flexor torque and power during late stance with

reduced knee power during early and midstance of the gait
cycle [65]. These decrements in gait are seen in the unaffected
limb of unilateral patients with PAD, demonstrating the
impact of this disease on functional status [65]. Thus, the use
of advanced biomechanical analysis to assess changes in gait
following exercise and surgical treatments must be explored
in future studies.
Despite multiple studies documenting the patency rate of
treatments in patients with PAD, there was a paucity of articles evaluating ST gait parameters following pharmacological, exercise, or revascularization treatments, severely limiting our ability to perform any meta-analysis. No articles were
found for the effect of pharmacological treatment on ST gait
parameters that included both pre- and posttreatment measurements using a within-patient design. In addition, only
one article was found for the effect of revascularization on
ST gait parameters, which focused solely on lower extremity
bypass. Potential reasons for the limited data include publication bias and lack of publications due to negative study
results. We attempted to limit this effect by searching multiple databases, including dissertation work. A formal metaanalysis, which aims to quantitatively combine the results of
different studies, could not be conducted in the current study
because the four articles selected for inclusion differed in
terms of the type of treatment and/or the length of time for
the treatment. Although walking velocity was assessed prior
to and following the treatment in each of the four articles,
three of the articles dealt with an exercise treatment, but the
exercise programs were of different durations: 3 months, 6
months, and 12 months, respectively [36, 38, 39]. The fourth
article assessed ST gait parameters three to four months after
revascularization [37]. Based on the yield of articles, additional studies that extend to 6 months or longer follow-up are
needed for both exercise and surgical treatments.
In conclusion, our study demonstrates significant lack of
research examining the effectiveness of treatments on ST gait
parameters in patients with PAD. From the four articles found
which reported pre- and posttreatment data, no significant
changes were demonstrated due to exercise or revascularization. Due to the limited data, additional studies are needed to
confirm these results. Further studies need to be performed
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to adequately address in a detailed and scientific manner the
effects of revascularization or alternative exercise protocols
on spatial and temporal gait parameters, in addition to
accepted clinical measurements, to provide a comprehensive
understanding of how such protocols may alter the gait of
patients with PAD. Moreover, advanced biomechanical gait
analysis should be performed to provide objective evaluation
of intrinsic components to gait (i.e., joint torques and powers)
to confirm the sensitivity of ST gait parameters to functional
changes in patients with PAD following intervention.
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